Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine

Author： Olin P.   Gustafsson L.   Barreto L.   Hessel L.   Mast T.C.   Rie A.V.   Bogaerts H.   Storsaeter J.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.21, Iss.17, 2003-05, pp. : 2024-2030

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An acellular pertussis vaccine in healthy adults: safety and immunogenicity

By Rothstein E.P.   Anderson E.L.   Decker M.D.   Poland G.A.   Reisinger K.S.   Blatter M.M.   Jacobson R.M.   Mink C.M.   Gennevois D.   Izu A.E.   Sinangil F.   Langenberg A.G.M.  

Vaccine, Vol. 17, Iss. 23, 1999-08 ,pp. : 2999-3006

Elsevier

Access to resources Recommend Favorite

Immunogenicity and reactogenicity of the Biken acellular pertussis vaccine in young adults

By Schmitt H.J.   Mohnike K.   Zepp F.   Herden P.   Hosbach P.  

Vaccine, Vol. 19, Iss. 4, 2000-10 ,pp. : 403-408

Elsevier

Access to resources Recommend Favorite

Efficacy of chemically cross-linked antigens for acellular pertussis vaccine

By Watanabe M.   Nagai M.   Funaishi K.   Endoh M.  

Vaccine, Vol. 19, Iss. 9, 2000-12 ,pp. : 1199-1203

Elsevier

Access to resources Recommend Favorite

Immunogenicity of a combined diphtheria-tetanus-acellular pertussis vaccine in adults

By Van Damme P.   Burgess M.  

Vaccine, Vol. 22, Iss. 3, 2004-01 ,pp. : 305-308

Elsevier

Access to resources Recommend Favorite

Analysis of Bordetella pertussis isolates collected in Japan before and after introduction of acellular pertussis vaccines

By Guiso N.   Boursaux-Eude C.   Weber C.   Hausman S.Z.   Sato H.   Iwaki M.   Kamachi K.   Konda T.   Burns D.L.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3248-3252

Elsevier

Access to resources Recommend Favorite